Amivantamab, an Epidermal Growth Factor Receptor (EGFR) and Mesenchymal-epithelial Transition Factor (MET) Bispecific Antibody, Designed to Enable Multiple Mechanisms of Action and Broad Clinical Applications
Byoung Chul Cho, Allison K. Simi, Joshua K. Sabari, Smruthi Vijayaraghavan, Sheri L. Moores, Alexander I. Spira
Topics & Concepts
Epidermal growth factor receptorMedicineCancer researchMesenchymal stem cellLung cancerTargeted therapyGrowth factor receptorAntibodyIn vivoMonoclonal antibodyImmune systemReceptorCancerImmunologyOncologyInternal medicineBiologyPathologyBiotechnologyLung Cancer Treatments and MutationsLung Cancer Research StudiesCancer therapeutics and mechanisms